News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News TCT 2016 Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making Yael L. Maxwell November 02, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
News Conference News TCT 2016 TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function Todd Neale November 01, 2016
News Conference News TCT 2016 Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field? Todd Neale October 30, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Conference News PCR London Valves 2016 MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation Shelley Wood September 19, 2016
News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News TVT 2016 Teenage TAVR: Should Practice Forge on While Guidelines Grow Up? Michael O'Riordan June 20, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Conference News TVT 2016 To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights Shelley Wood June 17, 2016
News Conference News TVT 2016 Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes Michael O'Riordan June 16, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 Planned MitraClip Implantation Safe, Feasible After TAVR, Small Series Suggests Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests Michael O'Riordan May 19, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016
News Conference News EuroPCR 2016 ‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR Yael L. Maxwell May 18, 2016
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016